Rank 23 • AI & Clinical Intelligence
Viz.ai
Uses artificial intelligence to analyze medical scans, accelerating diagnosis and treatment coordination for acute clinical conditions.
Visit website- Signal Score
- 90.6
- Total raised
- $250M
- Stage
- Series D+
- Founded
- 2016
- Headquarters
- San Francisco, USA
- Region
- North America
Their signal
Viz.ai is a pioneer in clinical AI coordination, with extensive FDA clearances and clinical validation showing drastically reduced times-to-treatment for stroke and cardiovascular emergencies.
Signal Score 90.6editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in AI & Clinical Intelligence
Did we miss something?
Change, add or remove details on this company. Our desk reviews every request.
Figures are subjective research desk estimates compiled from public sources and refreshed monthly, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.